| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 4 Sep 2026 | 31 Aug 2026 |
| Astal Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 inter alia to consider and approve 1. To Consider & to approve the Notice of 33rd Annual General Meeting of the Company along with fixing the day date time and Venue of Annual General Meeting of the Company; 2. To Approve Board Report along with all other necessary Annexure for the financial year ended March 31 2026; 3. To Appoint Scrutinizer to scrutinize voting during the AGM and remote e-voting; 4. Any other matter with the permission of chair. Submission of outcome of the meeting of the Board of Directors. (As Per BSE Announcement Dated on: 04/09/2026) | ||
| Board Meeting | 14 Aug 2026 | 9 Aug 2026 |
| Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Prior intimation of Board meeting to approve quarterly financial results for the quarter ended 30th June 2026. Submission of Outcome of Board Meeting. Submission of Financial Results for the quarter ended June 30, 2026. (As Per BSE Announcement Dated on:14.08.2026) | ||
| Board Meeting | 29 Jun 2026 | 29 Jun 2026 |
| Outcome of board meeting held on today i.e. 29th June, 2026. | ||
| Board Meeting | 30 May 2026 | 25 May 2026 |
| Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve 1. To Consider and Approve the audited standalone and Consolidated financial results for the quarter and year ended March 31 2026 along with limited review report of the auditors. 2. To consider and approve the audited standalone and consolidated financial statements of the Company for the financial year ended March 31 2026 along with report of the auditors. 3. To Appoint Internal Auditor for the Financial Year 2026-27. 4. Any other matter with the permission of chair. Outcome of Board Meeting held on Saturday, 30th May, 2026. (As Per BSE Announcement Dated on 30.05.2026) | ||
| Board Meeting | 25 May 2026 | 25 May 2026 |
| Outcome of Board meeting held today, 25th May, 2026. | ||
| Board Meeting | 12 May 2026 | 12 May 2026 |
| Submission of outcome of Board Meeting held on 12th May, 2026. | ||
| Board Meeting | 14 Feb 2026 | 10 Feb 2026 |
| Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve The unaudited standalone financial results for the quarter ended 31st December 2025 along with Limited Review Report of the auditors. Submission of Outcome of Board Meeting. Submission of Unaudited Financial Results for the quarter ended December 31, 2025. (As Per BSE Announcement Dated on:14.02.2026) | ||
| Board Meeting | 14 Jan 2026 | 14 Jan 2026 |
| Submission of Outcome of Board Meeting. | ||
| Board Meeting | 14 Nov 2025 | 10 Nov 2025 |
| Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve 1. To Consider and Approve the unaudited standalone financial results for the quarter and half year ended 30th September 2025 along with Limited Review Report of the auditors; 2. Any other matter with the permission of chair. Submission of outcome of the Board Meeting held on 14th November, 2025. (As Per BSE Announcement Dated on 14.11.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
